Posted: Nov 13, 2017
Haneen Shalabi, D.O., a Physician in the Pediatric Oncology Branch, received the 2017 Next Gen Award from the Children’s Cancer Foundation, Inc (CCF). As the highest award CCF presents to individual researchers, the Next Gen Award recognizes young investigators who are committed to pursuing a long-term career in pediatric oncology research. Read more...
Posted: Nov 13, 2017
Many cancer experts predict the newest innovation in cancer treatment will be the development of blood tests, called liquid or blood biopsies, that can monitor the growth of tumors by analyzing DNA shed from tumors into the bloodstream. A recent article from Axios highlights NCI’s initiative to support the development and validation of these tests through a partnership with engineers and clinical experts. Mark Roschewski, M.D., Staff Clinician in the Lymphoid Malignancies Branch, notes there is little doubt these tests will be available soon and says the “only question is when and at what breadth.” Read the full story…
Posted: Oct 17, 2017
Shiv Grewal, Ph.D., Chief of the Laboratory of Biochemistry and Molecular Biology, has been named an Indian National Science Academy (INSA) Foreign Fellow for his pioneering contributions on the role of epigenetic modifications in heterochromatin assembly and discovery of relation between heterochromatin assembly and RNAi. The INSA Foreign Fellowship is designated to scientists recognized as international leaders in their field. Dr. Grewal is one of four researchers to receive the 2017 fellowship.
Posted: Oct 11, 2017
Vassiliki Saloura, M.D., has joined the Thoracic and Gastrointestinal Oncology Branch (TGIB) as an Assistant Clinical Investigator. Dr. Saloura’s laboratory investigates the role of histone and non-histone protein methylation in tumor growth, therapy resistance and immunogenicity in squamous cell carcinoma of the aerodigestive tract. Learn more . . .
Posted: Oct 2, 2017
H. Efsun Arda, Ph.D., has joined the Laboratory of Receptor Biology and Gene Expression (LRBGE) as a Stadtman tenure track investigator. Dr. Arda spearheaded the development of genomic and epigenetic analysis of primary pancreatic cells obtained from children and adult donors using single cell analysis. Her research focuses on understanding the genomic information that governs development, differentiation and function of pancreatic cell lineages. Learn more...
Posted: Sep 25, 2017
The American Society for Microbiology (ASM) has selected Nicholas Restifo, M.D., Senior Investigator in the Surgery Branch, to receive the 2018 ASM Award in Clinical and Diagnostic Immunology. The award recognizes scientists for their outstanding contributions to microbiology in service of science and the public. Learn more…
CCR’s Douglas Lowy and John Schiller receive the 2017 Lasker~DeBakey Clinical Medical Research Award
Posted: Sep 6, 2017
Douglas Lowy, M.D., and John Schiller, Ph.D., of CCR’s Laboratory of Cellular Oncology have received the 2017 Lasker~DeBakey Clinical Medical Research Award for their groundbreaking research leading to the development of human papillomavirus (HPV) vaccines. The Lasker Awards are widely regarded as the country’s most prestigious biomedical research prizes.
Posted: Aug 29, 2017
The Biophysical Society has selected Sriram Subramaniam, Ph.D., Senior Investigator in the Laboratory of Cell Biology, as a 2018 Fellow for his seminal contributions to the cryo-EM field and related disciplines, including electron tomography and focused ion beam imaging. Along with other distinguished members who have demonstrated excellence in science and contributed to the expansion of the field of biophysics, Dr. Subramaniam will be honored during the Awards Ceremony of the Biophysical Society’s Annual Meeting on February 19, 2018 in San Francisco. Learn more...
Posted: Aug 16, 2017
Kevin Camphausen, M.D., Chief of CCR’s Radiation Oncology Branch, is among 23 distinguished members of the American Society for Radiation Oncology (ASTRO) to receive fellowship designation. Since 2006, the ASTRO Fellowship has been awarded to physicians and medical physicists making significant contributions to the field of radiation oncology in research, patient care, education and leadership. Dr. Camphausen will receive his award during ASTRO’s Annual Meeting, held September 24-27, 2017, in San Diego.
Posted: Aug 9, 2017
Freddie Escorcia, M.D., Ph.D., has been appointed as an Assistant Clinical Investigator in the Molecular Imaging Program (MIP). Dr. Escorcia's work focuses on tumor-targeted, personalized cancer treatment. Targeted radionuclide therapy provides an orthogonal mode of cell killing that is distinct from, yet complementary to, existing small molecule and chemotherapy treatments. Learn more...